
<!doctype html><html lang="en"> <head><meta charset="utf-8"> 
<title>s800 inconsistencies</title> 
<style>

.gray { background-color:rgba(125, 125, 125, 0.5); } 
.orange { background-color:rgba(210, 180, 180, 0.5); } 

.match { text-decoration: underline; 
/*
  -webkit-text-decoration-color: red;  
  text-decoration-color: red; */
    -webkit-text-decoration-line: overline underline; /* Safari */
   text-decoration-line: overline underline; 
   color:yellow;
/*   font-weight:bold; */
  
  
  } 
.LINNAEUS_only { background-color: rgba(125, 125, 125, 0.5); }
.annotated { background-color:rgba(50, 180, 180, 0.5); } 
.unannotated { background-color:rgba(214, 75, 79, 0.5); } 

.match_species { text-decoration: underline; } 
/*
ul#menu li {
/*  display:inline; 
}
.horizontal { display: inline; border-left: 3px solid darkorange; padding-left: 0.3em; }
.first { border-left: none; padding-left: 0; }
*/
ul#menu li {
list-style-type: circle;
}
table { border-collapse: collapse; } 
th, td { border: 1px solid orange; padding: 4px; } 
th {  cursor: pointer; } 
th:hover { background: yellow; }

html, body, iframe { height: 100%; }

* {
  box-sizing: border-box;
}

.row {
  display: flex;
}


/* Create two equal columns that sits next to each other */
.column {
  flex: 50%;
  padding: 0px;
 /*height: 300px; /* Should be removed. Only for demonstration */
}
/* Create two equal columns that sits next to each other */
.column1 {
  flex: 30%;
  padding: 0px;
 /*height: 300px; /* Should be removed. Only for demonstration */
}
/* Create two equal columns that sits next to each other */
.column2 {
  flex: 70%;
  padding: 0px;
 /*height: 300px; /* Should be removed. Only for demonstration */
}
 
</style></head><body>
<h2>21034775</h2><span class="unannotated">not annotated</span> - <span class="annotated">annotated</span> - <span class="LINNAEUS_only">LINNAEUS only</span><br><hr>Cross-genotypic polyclonal anti-<span class="annotated ">HCV</span> antibodies from <span class="annotated ">human</span> ascitic fluid.<br><br>Many anti-<span class="annotated ">HCV</span> antibodies are available, but more are needed for research and clinical applications. This study examines whether ascitic fluid from cirrhotic <span class="LINNAEUS_only ">patients</span> could be a source of reagent-grade antibodies. Ascitic fluid from 29 <span class="annotated ">HCV</span> <span class="LINNAEUS_only ">patients</span> was screened by ELISA for anti-<span class="annotated ">HCV</span> antibodies against three <span class="unannotated ">viral</span> proteins: core, NS4B, and NS5A. Significant patient-to-patient variability in anti-<span class="annotated ">HCV</span> antibody titers was observed. Total ascitic fluid IgG purified by Protein-A chromatography reacted with <span class="annotated ">HCV</span> proteins in immunoblots, cell extracts, and replicon-expressing cells. Affinity-purification using synthetic peptides as bait allowed the preparation of cross-genotypic antibodies directed against pre-selected regions of <span class="unannotated ">HCV</span> core, NS4B, and NS5A proteins. The performance of the polyclonal antibodies was comparable to that of monoclonal antibodies. Anti-NS4B antibody preparations reacted with genotype 1a, 1b, and 2a NS4B proteins in immunoblots and allowed NS4B to be localized in replicon-expressing cells. Ascitic fluid is an abundant source of <span class="annotated ">human</span> polyclonal cross-genotypic antibodies that can be used as an alternative to blood. This study shows the utility of selectively purifying <span class="annotated ">human</span> polyclonal antibodies from ascitic fluid. Affinity purification allows antibodies to be selected that are comparable to monoclonal antibodies in their ability to react with targeted regions of <span class="unannotated ">viral</span> proteins. 
<br><br><br><hr><h3>Ann file</h3><pre>T1	Species 32 35	HCV<br><br>N1	Reference T1 Taxonomy:11103<br><br>T2	Species 52 57	human<br><br>N2	Reference T2 Taxonomy:9606<br><br>T3	Species 84 87	HCV<br><br>N3	Reference T3 Taxonomy:11103<br><br>T4	Species 309 312	HCV<br><br>N4	Reference T4 Taxonomy:11103<br><br>T5	Species 353 356	HCV<br><br>N5	Reference T5 Taxonomy:11103<br><br>T6	Species 471 474	HCV<br><br>N6	Reference T6 Taxonomy:11103<br><br>T7	Species 579 582	HCV<br><br>N7	Reference T7 Taxonomy:11103<br><br>T8	Species 1133 1138	human<br><br>N8	Reference T8 Taxonomy:9606<br><br>T9	Species 1276 1281	human<br><br>N9	Reference T9 Taxonomy:9606<br><br></pre></body></html>